These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 33814471)

  • 1. Added-value of spasticity reduction to improve arm-hand skill performance in sub-acute stroke patients with a moderately to severely affected arm-hand.
    Franck JA; Smeets RJEM; Elmanowski J; Renders K; Seelen HAM
    NeuroRehabilitation; 2021; 48(3):321-336. PubMed ID: 33814471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating the functional outcomes of ultrasound-guided botulinum toxin type A injections using the Euro-musculus approach for upper limb spasticity treatment in post-stroke patients: an observational study.
    Buyukavci R; Akturk S; Ersoy Y
    Eur J Phys Rehabil Med; 2018 Oct; 54(5):738-744. PubMed ID: 29422486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study.
    Sun SF; Hsu CW; Sun HP; Hwang CW; Yang CL; Wang JL
    Neurorehabil Neural Repair; 2010 Jan; 24(1):34-41. PubMed ID: 19729582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of botulinum toxin A in upper limb function of hemiplegic patients.
    Rousseaux M; Kozlowski O; Froger J
    J Neurol; 2002 Jan; 249(1):76-84. PubMed ID: 11954872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is the reduction of spasticity by botulinum toxin a beneficial for the recovery of motor function of arm and hand in stroke patients?
    Woldag H; Hummelsheim H
    Eur Neurol; 2003; 50(3):165-71. PubMed ID: 14530623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are we underestimating the clinical efficacy of botulinum toxin (type A)? Quantifying changes in spasticity, strength and upper limb function after injections of Botox to the elbow flexors in a unilateral stroke population.
    Pandyan AD; Vuadens P; van Wijck FM; Stark S; Johnson GR; Barnes MP
    Clin Rehabil; 2002 Sep; 16(6):654-60. PubMed ID: 12392341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis prediction of the effect of botulinum toxin therapy and intensive rehabilitation on the upper arm function in post-stroke patients using hierarchical cluster analysis.
    Hara T; Niimi M; Yamada N; Shimamoto Y; Masuda G; Hara H; Abo M
    Disabil Rehabil; 2022 Nov; 44(22):6815-6823. PubMed ID: 34547217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botuloscope: 1-year follow-up of upper limb post-stroke spasticity treated with botulinum toxin.
    Marque P; Denis A; Gasq D; Chaleat-Valayer E; Yelnik A; Colin C; ; Pérennou D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):207-213. PubMed ID: 31229700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a functional hand orthosis combined with electrical stimulation adjunct to arm-hand rehabilitation in subacute stroke patients with a severely to moderately affected hand function.
    Franck JA; Smeets RJEM; Seelen HAM
    Disabil Rehabil; 2019 May; 41(10):1160-1168. PubMed ID: 29316821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. How could robotic training and botolinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study.
    Pennati GV; Da Re C; Messineo I; Bonaiuti D
    Eur J Phys Rehabil Med; 2015 Aug; 51(4):381-7. PubMed ID: 25358636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report.
    Hirakawa Y; Koyama S; Tanabe S; Takeda K; Ueda T; Motoya I; Sakurai H; Kanada Y; Kawamura N; Kawamura M; Nagata J; Kanno T
    J Hand Ther; 2019; 32(4):519-524. PubMed ID: 30025843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.
    Demetrios M; Gorelik A; Louie J; Brand C; Baguley IJ; Khan F
    J Rehabil Med; 2014 Sep; 46(8):730-7. PubMed ID: 25073939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
    Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
    Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined therapy using botulinum toxin A and single-joint hybrid assistive limb for upper-limb disability due to spastic hemiplegia.
    Saita K; Morishita T; Hyakutake K; Fukuda H; Shiota E; Sankai Y; Inoue T
    J Neurol Sci; 2017 Feb; 373():182-187. PubMed ID: 28131185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cortical activity modulation by botulinum toxin type A in patients with post-stroke arm spasticity: real and imagined hand movement.
    Veverka T; Hluštík P; Hok P; Otruba P; Tüdös Z; Zapletalová J; Krobot A; Kaňovský P
    J Neurol Sci; 2014 Nov; 346(1-2):276-83. PubMed ID: 25255982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A injection, followed by home-based functional training for upper limb hemiparesis after stroke.
    Takekawa T; Kakuda W; Taguchi K; Ishikawa A; Sase Y; Abo M
    Int J Rehabil Res; 2012 Jun; 35(2):146-52. PubMed ID: 22453625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke.
    Sun SF; Hsu CW; Hwang CW; Hsu PT; Wang JL; Yang CL
    Phys Ther; 2006 Oct; 86(10):1387-97. PubMed ID: 17012643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience in using xeomin in the treatment of arm and hand spasticity in the early rehabilitation phase of stroke].
    Kostenko EV; Petrova LV; Ganzhula PA; Lisenker LN; Otcheskaia OV; Khozova AA; Boĭko AN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):29-34. PubMed ID: 22677662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of backward treadmill training and botulinum toxin type A therapy on gait and balance in patients with chronic stroke: A pilot, single-blind, randomized controlled trial.
    Munari D; Serina A; Disarò J; Modenese A; Filippetti M; Gandolfi M; Smania N; Picelli A
    NeuroRehabilitation; 2020; 46(4):519-528. PubMed ID: 32508341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapeutic application of botulinum toxin type A, low-frequency rTMS, and intensive occupational therapy for post-stroke spastic upper limb hemiparesis.
    Kakuda W; Abo M; Momosaki R; Yokoi A; Fukuda A; Ito H; Tominaga A; Umemori T; Kameda Y
    Eur J Phys Rehabil Med; 2012 Mar; 48(1):47-55. PubMed ID: 22071503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.